Matsuda Kazuko — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Matsuda Kazuko is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Kazuko Matsuda is the Chief Medical Officer of MediciNova Inc., a biopharmaceutical company focused on small-molecule therapeutics for neurological and fibrotic diseases. Based on the SEC filing dated January 20, 2026, she holds the CMO role and is involved in leading clinical development and medical strategy for MNOV’s portfolio, including MN-001, MN-166, and MN-221.
Role
Chief Medical Officer
Notability
40/100
Board memberships
MediciNova Inc (MNOV)
Awards & honors
Leads clinical development and medical strategy for MediciNova's portfolio, including MN-001, MN-166, and MN-221
Oversees medical affairs and regulatory interactions to advance neurological and fibrotic disease programs
Frequently Asked Questions
Who is Matsuda Kazuko?
Kazuko Matsuda is the Chief Medical Officer of MediciNova Inc., a biopharmaceutical company focused on small-molecule therapeutics for neurological and fibrotic diseases. Based on the SEC filing dated January 20, 2026, she holds the CMO role and is involved in leading clinical development and medical strategy for MNOV’s portfolio, including MN-001, MN-166, and MN-221.…
Where can I see all of Matsuda Kazuko's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
